FDA approves pritelivir for refractory HSV lesions - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

FDA approves pritelivir for refractory HSV lesions

  • By

  • Teraya Smith

  • October 9, 2026

  • 2 min

Share

Original Source(s)

Related Content